Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01197352 · ClinicalTrials.gov registry record · NA
Pilot Study of a Text Message Platform to Reduce Risky Drinking in Young Adults
A NA study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT01197352: Completed NA study, sponsored by University of Pittsburgh.
NCT01197352 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 45 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01197352, a NA study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
Young adults are in a critical period where they can be influenced to avoid a trajectory of high-risk drinking and harmful outcomes in the later adult years. The Emergency Department might offer a unique opportunity to reach young adults, if an easy to implement screening, brief intervention and referral to treatment was available. The investigators are investigating the feasibility and accuracy of ED-initiated and outpatient-continued assessment of drinking behavior in young adults using a computer-driven text messaging platform. Based on the subject's response to weekly assessments, the computer platform will send personalized motivational messages in real-time.
Primary Outcome
We will report the proportion of weeks with completed drinking assessments in the EA and EA\&I groups.
Interventions
- BEHAVIORAL Motivational and Normative Feedback
- BEHAVIORAL Self-Awareness
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2010-08 |
| Est. Completion | 2011-02 |
| Phase | NA |
What the finished NCT01197352 record still lists
NCT01197352 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Motivational and Normative Feedback is the first listed.
NCT01197352 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01197352 about?
NCT01197352 is a clinical study titled "Pilot Study of a Text Message Platform to Reduce Risky Drinking in Young Adults". Young adults are in a critical period where they can be influenced to avoid a trajectory of high-risk drinking and harmful outcomes in the later adult years. The Emergency Department might offer a unique opportunity to reach young adults, if an easy to implement screening, brief intervention and ref...
What is the current status of trial NCT01197352?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2010-08. Estimated completion is 2011-02.
What interventions are being tested in trial NCT01197352?
The interventions under investigation include: Motivational and Normative Feedback (BEHAVIORAL), Self-Awareness (BEHAVIORAL).
Who is sponsoring clinical trial NCT01197352?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01197352's enrollment target sits among peer trials
45 1411th of 2000 higher than 578 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia